The Sidney & Lois Eskenazi Hospital is a public hospital located in Indianapolis, Indiana. The hospital is the flagship medical center for Eskenazi Health, founded in 1859 as Indiana's oldest public healthcare system. The hospital is operated by Health & Hospital Corporation of Marion County.

There are 315 beds in Eskenazi Health.

During the past decade, Eskenazi Health conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 11 clinical trials were completed, i.e. on average, 22.9% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 7 clinical trials were completed. i.e. 35% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eskenazi Health" #1 sponsor was "Indiana University" with 43 trials, followed by "Major Extremity Trauma Research Consortium" with 6 trials sponsored, "Gen-Probe, Incorporated" with 4 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored and "Meridian Bioscience, Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eskenazi Health" #1 collaborator was "National Institute on Aging (NIA)" with 11 trials as a collaborator, "National Institutes of Health (NIH)" with 6 trials as a collaborator, "Regenstrief Institute, Inc." with 3 trials as a collaborator, "Vanderbilt University" with 3 trials as a collaborator and "Eskenazi Health" with 2 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Eskenazi Health" are "Alzheimer Disease" (3 trials), "Colorectal Cancer" (3 trials), "Delirium" (3 trials), "Dementia" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Eskenazi Health" in a lesser frequency.

Most popular intervention types in "Eskenazi Health" are "Other" (19 trials), "Behavioral" (17 trials), "Device" (15 trials), "Drug" (14 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Attention Control" (3 trials), "Usual Care" (3 trials), "Apixaban" (2 trials), "Cologuard" (2 trials) and "Rivaroxaban" (2 trials). Other intervention names were less common.

The vast majority of trials in "Eskenazi Health" are 59 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Eskenazi Health". 1 are not yet recruiting, 13 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Eskenazi Health, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Eskenazi Health, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 42 trials that are defined as “Not Applicable".